Correlation Between Mediwound and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mediwound and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediwound and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediwound and Travere Therapeutics, you can compare the effects of market volatilities on Mediwound and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediwound with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediwound and Travere Therapeutics.
Diversification Opportunities for Mediwound and Travere Therapeutics
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mediwound and Travere is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Mediwound and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Mediwound is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediwound are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Mediwound i.e., Mediwound and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Mediwound and Travere Therapeutics
Given the investment horizon of 90 days Mediwound is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Mediwound is 1.23 times less risky than Travere Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 1,750 in Travere Therapeutics on September 1, 2024 and sell it today you would earn a total of 131.00 from holding Travere Therapeutics or generate 7.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mediwound vs. Travere Therapeutics
Performance |
| Timeline |
| Mediwound |
| Travere Therapeutics |
Mediwound and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mediwound and Travere Therapeutics
The main advantage of trading using opposite Mediwound and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediwound position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Mediwound vs. Foghorn Therapeutics | Mediwound vs. Eliem Therapeutics | Mediwound vs. Sutro Biopharma | Mediwound vs. Dyadic International |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |